USPTO 2015–2025 USPTO PatentsView US Corporation

CF Traverse LLC

USPTO PatentsView assignee record - 22 granted patents across 7 technology areas, recorded in grant years 2018–2022. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: Y02E (Reduction OF Greenhouse GAS [GHG] Emissions, Related TO Energy Generation, Transmission OR Distribution).

RSS updates for this company

The verdict

According to USPTO PatentsView, CF ranks #13,353 of 49,997 tracked US assignees by granted-patent volume, with 22 patents across 7 technology areas.

#13,353
of 49,997 US assignees by volume
36th percentile
by Innovation Score (30.8/100)
16.3
avg claims per patent
+75%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R13353 · US Corporation #13,353 · 22 grants

GRANTS-SMALL · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL

  • GRANTS-SMALL 22 grants
  • MID-PACK #13,353/49,997
  • PHOTO-FINISH Carl Zeiss Meditec…
  • CPC-NARROW Y02E · 7 areas
  • INNOV-THIN 30.8/100
  • CLAIMS-RICH 16.3 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-SURGE +75% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Carl Zeiss Meditec Cataract Technology Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How CF’s 30.8 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around CF

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows CF's Innovation Score is 30.8/100 (36th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for CF?

Each dot is one of CF’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). CF’s own 16.3 claims/patent is ABOVE the 13.9 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

CF vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 21.921.92222.1 5101520253035 Granted patents (volume) Avg claims / patent Carl Zeiss Meditec Cataract Technology Inc. - 22, 29.36Carl Zeiss Medite…Cast Co., Ltd. - 22, 17.09CastCefla Societa' Cooperativa - 22, 8.41Cefla Societa' Co…Celloptic, Inc. - 22, 16.59CellopticChangs Ascending Enterprise Co., Ltd. - 22, 9.68Changs Ascending…Chassis Brakes International B.V. - 22, 13.95Chassis Brakes In…Chevron Oronite Technology B.V. - 22, 16.64Chevron Oronite T…Clariant Production (FRANCE) S.A.S. - 22, 9.14Clariant Producti…CF Traverse LLC - 22, 16.27CF Traverse
CF vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where CF's grants concentrate

CF Traverse LLC is a focused PatentsView assignee: 7 CPC subclasses with 100% of grants classified under Y02E (Reduction OF Greenhouse GAS [GHG] Emissions, Related TO Energy Generation, Transmission OR Distribution). Peak complete grant year is 2020 (7 grants) versus a trough of 2 in 2022. By volume, CF sits between Carl Zeiss Meditec Cataract Technology Inc. and Clariant Production (FRANCE) S.A.S..

CF's three-year grant acceleration

CF Traverse LLC shows 2 grants in 2022–2024 against only 15 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at CF's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows CF holds 22 patents at rank #13,347, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near CF

By rank, the assignees closest to #13,347 in granted patent volume.

Leaders in Y02E (Reduction OF Greenhouse GAS [GHG] Emissions)

Other assignees with the most granted patents in CF's primary technology class.

CF's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

31 36th percentile higher than 36% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

02468 20182019202020212022 2
USPTO utility patent grants by year · 2018–2022

Grants by year

Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.

View data table
CF Traverse LLC patent grants by year, 2015–2025
Year Patents Granted Share of Period
2018 5 22.7%
2019 3 13.6%
2020 7 31.8%
2021 5 22.7%
2022 2 9.1%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

CF Traverse LLC's patent record in context - here's where to go next.

  • CF Traverse LLC's lead technology class is Y02E (Reduction OF Greenhouse GAS [GHG] Emissions, Related TO Energy Generation, Transmission OR Distribution), 100% of its portfolio - see every assignee active in that class. Explore Y02E
  • Ranked #13,353 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare CF Traverse LLC against Carl Zeiss Meditec Cataract Technology Inc., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 30.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.